Details for New Drug Application (NDA): 203663
✉ Email this page to a colleague
The generic ingredient in BEXAROTENE is bexarotene. There are seven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the bexarotene profile page.
Summary for 203663
Tradename: | BEXAROTENE |
Applicant: | Hikma |
Ingredient: | bexarotene |
Patents: | 0 |
Suppliers and Packaging for NDA: 203663
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BEXAROTENE | bexarotene | CAPSULE;ORAL | 203663 | ANDA | Hikma Pharmaceuticals USA Inc. | 0054-0399 | 0054-0399-25 | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (0054-0399-25) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 75MG | ||||
Approval Date: | Jun 16, 2020 | TE: | AB | RLD: | No |
Complete Access Available with Subscription